Back
Columbus McKinnon 10K Form
Sell
38
CMCO
Columbus McKinnon
Last Price:
$14.69
Seasonality Move:
4.37%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-01-31 | 10Q | CMCO/Columbus McKinnon Quarterly |
2023-11-01 | 10Q | CMCO/Columbus McKinnon Quarterly |
2023-08-02 | 10Q | CMCO/Columbus McKinnon Quarterly |
2023-05-25 | 10K | CMCO/Columbus McKinnon Annual |
2023-02-01 | 10Q | CMCO/Columbus McKinnon Quarterly |
2022-10-27 | 10Q | CMCO/Columbus McKinnon Quarterly |
Receive CMCO News And Ratings
See the #1 stock for the next 7 days that we like better than CMCO
CMCO Financial Statistics
Sales & Book Value
Annual Sales: | $963M |
---|---|
Cash Flow: | $29.5M |
Price / Cash Flow: | 16.47 |
Annual Sales: | $30.82 |
Price / Book: | 0.45 |
Profitability
EPS (TTM): | -0.17000 |
---|---|
Net Income (TTM): | $-5.1M |
Gross Margin: | $325.7M |
Return on Equity: | -0.58% |
Return on Assets: | -0.29% |
Columbus McKinnon Earnings Forecast
Key Columbus McKinnon Financial Ratios
-
The Gross Profit Margin over the past 30 years for CMCO is 33.82%.
-
The Selling, General & Administrative Expenses for CMCO have been equal to 22.56% of Gross Profit Margin.
-
The Research & Development expenses have been 2.48% of Revenue.
-
The Net Earning history of CMCO is -0.53% of Total Revenues.
-
Per Share Earnings over the last 30 years have been positive in 14 years.
Columbus McKinnon Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Machinery |
Sector: | Industrials |
Current Symbol: | CMCO |
CUSIP: | 199333 |
Website: | cmco.com |
Debt
Debt-to-Equity Ratio: | 0.52 |
---|---|
Current Ratio: | 1.81 |
Quick Ratio: | 0.85 |
Price-to-Earnings
Trailing P/E Ratio: | 9.74 |
---|---|
Forward P/E Ratio: | 4.72 |
CMCO Technical Analysis vs Fundamental Analysis
Sell
38
Columbus McKinnon (CMCO)
is a Sell
Is Columbus McKinnon a Buy or a Sell?
-
Columbus McKinnon stock is rated a SellThe current Columbus McKinnon [CMCO] share price is $13.80. The Score for CMCO is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.